Arecor Therapeutics plc (AIM:AREC)
London · Delayed Price · Currency is GBP · Price in GBX 81.40
+1.40 (1.75%)
Dec 12, 2025, 4:12 PM GMT+1
Arecor Therapeutics Market Cap
Arecor Therapeutics has a market cap or net worth of 30.21 million as of December 12, 2025. Its market cap has increased by 4.58% in one year.
Market Cap
30.21M
Enterprise Value
28.49M
Revenue
5.06M
Ranking
n/a
PE Ratio
n/a
Stock Price
81.40
Market Cap Chart
Since June 3, 2021, Arecor Therapeutics's market cap has decreased from 66.99M to 30.21M, a decrease of -54.91%. That is a compound annual growth rate of -16.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 11, 2025 | 30.21M | 8.84% |
| Dec 31, 2024 | 27.75M | -50.35% |
| Dec 29, 2023 | 55.89M | -23.94% |
| Dec 30, 2022 | 73.48M | -34.00% |
| Dec 31, 2021 | 111.34M | 66.19% |
| Jun 3, 2021 | 66.99M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 210.77B |
| GSK plc | 72.41B |
| Haleon | 31.72B |
| Smith & Nephew | 10.61B |
| Convatec Group | 4.39B |
| Hikma Pharmaceuticals | 3.39B |
| HUTCHMED (China) | 1.77B |
| Genus | 1.73B |